On Tuesday, IDEXX Laboratories hit an important technical milestone, seeing its Relative Strength (RS) Rating jump into the 80-plus percentile with an improvement to 83, up from 78 the day before.
Hone Your Stock-Picking Skills By Focusing On These Factors
This exclusive rating from Investor's Business Daily identifies share price movement with a 1 (worst) to 99 (best) score. The grade shows how a stock's price behavior over the trailing 52 weeks stacks up against all the other stocks in our database.
Decades of market research reveals that the top-performing stocks typically have an RS Rating north of 80 in the early stages of their moves.
IDEXX Laboratories is trying to complete a consolidation with a 583.39 buy point. See if the stock can clear the breakout price in volume at least 40% above average.
IDEXX Laboratories showed 7% EPS growth in the latest quarterly report, while sales growth came in at 4%.
IDEXX Laboratories holds the No. 5 rank among its peers in the Medical-Systems/Equipment industry group. Intuitive Surgical is the top-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Which Stocks Are Showing Rising Relative Strength?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
